Imke Atreya

3.6k total citations · 1 hit paper
71 papers, 2.7k citations indexed

About

Imke Atreya is a scholar working on Immunology, Genetics and Surgery. According to data from OpenAlex, Imke Atreya has authored 71 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Immunology, 29 papers in Genetics and 15 papers in Surgery. Recurrent topics in Imke Atreya's work include Immune Cell Function and Interaction (29 papers), Inflammatory Bowel Disease (28 papers) and T-cell and B-cell Immunology (20 papers). Imke Atreya is often cited by papers focused on Immune Cell Function and Interaction (29 papers), Inflammatory Bowel Disease (28 papers) and T-cell and B-cell Immunology (20 papers). Imke Atreya collaborates with scholars based in Germany, United Kingdom and United States. Imke Atreya's co-authors include Markus F. Neurath, Raja Atreya, Sebastian Zundler, Stefan Wirtz, Rocío López-Posadas, Clemens Neufert, Timo Räth, Anika Fischer, Alastair J.M. Watson and Kai Hildner and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and The Journal of Experimental Medicine.

In The Last Decade

Imke Atreya

68 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

NF‐κB in inflammatory bowel disease

2008 678 citations Imke Atreya, Raja Atreya et al. profile →

Peers

Imke Atreya

IMMUN

GENET

EPIDE

ONCOL

Paolo Biancheri Italy

Stefania Vetrano Italy

Jakob Benedict Seidelin Denmark

Massimiliano Sarra Italy

Dirk Seegert Germany

Eleonora Franzè Italy

Irene Marafini Italy

Andreas Lügering Germany

Ehud Zigmond Israel

Nadia Corazza Switzerland

Paolo Biancheri Italy

Imke Atreya

1.2k ×0.9

IMMUN

1.2k ×1.2

GENET

705 ×1.1

662 ×1.5

EPIDE

277 ×0.6

ONCOL

Citations per year, relative to Imke Atreya Imke Atreya (= 1×) peers Paolo Biancheri

Countries citing papers authored by Imke Atreya

Since Specialization

Citations

This map shows the geographic impact of Imke Atreya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Imke Atreya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Imke Atreya more than expected).

Fields of papers citing papers by Imke Atreya

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Imke Atreya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Imke Atreya. The network helps show where Imke Atreya may publish in the future.

Co-authorship network of co-authors of Imke Atreya

This figure shows the co-authorship network connecting the top 25 collaborators of Imke Atreya. A scholar is included among the top collaborators of Imke Atreya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Imke Atreya. Imke Atreya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wiendl, Maximilian, Lijuan Liu, Francesco Vitali, et al.. (2024). Etrolizumab-s fails to control E-Cadherin-dependent co-stimulation of highly activated cytotoxic T cells. Nature Communications. 15(1). 1043–1043. 2 indexed citations

Atreya, Imke & Markus F. Neurath. (2024). Linking IL-10 signaling with lipid metabolic programs in macrophages: dysregulated ceramide homeostasis drives colitis. Signal Transduction and Targeted Therapy. 9(1). 156–156.

Becker, Emily, Lijuan Liu, Tanja M. Müller, et al.. (2023). Differential Effects of Ontamalimab Versus Vedolizumab on Immune Cell Trafficking in Intestinal Inflammation and Inflammatory Bowel Disease. Journal of Crohn s and Colitis. 17(11). 1817–1832. 4 indexed citations

Wiendl, Maximilian, Tanja M. Müller, Imke Atreya, et al.. (2023). Nr4a1-dependent non-classical monocytes are important for macrophage-mediated wound healing in the large intestine. Frontiers in Immunology. 13. 1040775–1040775. 5 indexed citations

Müller, Tanja M., Carol‐Immanuel Geppert, Ines Schneider, et al.. (2022). Vedolizumab blocks α4β7 integrin-mediated T cell adhesion to MAdCAM-1 in microscopic colitis. Therapeutic Advances in Gastroenterology. 15. 1098281875–1098281875. 8 indexed citations

Schneider, Ines, Donata Lissner, Rainer Glauben, et al.. (2022). Expression and function of α4β7 integrin predict the success of vedolizumab treatment in inflammatory bowel disease. Translational research. 253. 8–15. 13 indexed citations

Müller, Tanja M., Ines Schneider, Carol‐Immanuel Geppert, et al.. (2021). α4β7 integrin-dependent adhesion of T cells to MAdCAM-1 is blocked by vedolizumab in patients with chronic refractory pouchitis. Therapeutic Advances in Gastroenterology. 14. 1088237683–1088237683. 2 indexed citations

Frey, Benjamin, Ina Becker, Imke Atreya, et al.. (2021). Transcriptomes of MPO-Deficient Patients with Generalized Pustular Psoriasis Reveals Expansion of CD4+ Cytotoxic T Cells and an Involvement of the Complement System. Journal of Investigative Dermatology. 142(8). 2149–2158.e10. 10 indexed citations

Neurath, Markus F., et al.. (2021). Innate Lymphoid Cells as Regulators of Epithelial Integrity: Therapeutic Implications for Inflammatory Bowel Diseases. Frontiers in Medicine. 8. 656745–656745. 29 indexed citations

10.

Wiendl, Maximilian, Raja Atreya, Timo Räth, et al.. (2019). Non-classical monocyte homing to the gut via α4β7 integrin mediates macrophage-dependent intestinal wound healing. Gut. 69(2). 252–263. 79 indexed citations

11.

Zundler, Sebastian, Anika Klingberg, Sarah Fischer, et al.. (2017). Three-Dimensional Cross-Sectional Light-Sheet Microscopy Imaging of the Inflamed Mouse Gut. Gastroenterology. 153(4). 898–900. 20 indexed citations

12.

Zundler, Sebastian, Anika Fischer, Raja Atreya, et al.. (2017). The α4β1 Homing Pathway Is Essential for Ileal Homing of Crohnʼs Disease Effector T Cells In Vivo. Inflammatory Bowel Diseases. 23(3). 379–391. 81 indexed citations

13.

Atreya, Raja, Simon Hirschmann, Sarah Fischer, et al.. (2017). Clinical Response to Vedolizumab in Ulcerative Colitis Patients Is Associated with Changes in Integrin Expression Profiles. Frontiers in Immunology. 8. 764–764. 41 indexed citations

14.

Voskens, Caroline, Anika Fischer, Carmen Lorenz, et al.. (2017). Characterization and Expansion of Autologous GMP-ready Regulatory T Cells for TREG-based Cell Therapy in Patients with Ulcerative Colitis. Inflammatory Bowel Diseases. 23(8). 1348–1359. 26 indexed citations

15.

Fischer, Anika, Sebastian Zundler, Raja Atreya, et al.. (2015). Differential effects of α4β7 and GPR15 on homing of effector and regulatory T cells from patients with UC to the inflamed gut in vivo. Gut. 65(10). 1642–1664. 120 indexed citations

16.

Neufert, Clemens, Christoph Becker, Özlem Türeci, et al.. (2013). Tumor fibroblast–derived epiregulin promotes growth of colitis-associated neoplasms through ERK. Journal of Clinical Investigation. 123(4). 1428–1443. 93 indexed citations

17.

Mudter, Jonas, Mirjam Schenk, Anne Brüstle, et al.. (2008). The transcription factor IFN regulatory factor–4 controls experimental colitis in mice via T cell–derived IL-6. Journal of Clinical Investigation. 118(7). 2415–26. 100 indexed citations

18.

Hildner, Kai, Peter Schirmacher, Imke Atreya, et al.. (2007). Targeting of the Transcription Factor STAT4 by Antisense Phosphorothioate Oligonucleotides Suppresses Collagen-Induced Arthritis. The Journal of Immunology. 178(6). 3427–3436. 54 indexed citations

19.

Atreya, Imke, C Schimanski, Christoph Becker, et al.. (2007). The T-box transcription factor eomesodermin controls CD8 T cell activity and lymph node metastasis in human colorectal cancer. Gut. 56(11). 1572–1578. 32 indexed citations

20.

Siebler, Juergen, Stefan Wirtz, Benno Weigmann, et al.. (2006). IL-28A Is a Key Regulator of T-Cell–Mediated Liver Injury via the T-Box Transcription Factor T-Bet. Gastroenterology. 132(1). 358–371. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact